Somatization in dermatology.
Journal
Skin health and disease
ISSN: 2690-442X
Titre abrégé: Skin Health Dis
Pays: England
ID NLM: 9918227353706676
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
19
04
2022
revised:
19
08
2022
accepted:
24
08
2022
entrez:
8
12
2022
pubmed:
9
12
2022
medline:
9
12
2022
Statut:
epublish
Résumé
Medically unexplained dermatologic symptoms, such as pruritus, numbness and burning are known as somatization. These cutaneous symptoms can be very difficult to treat because of an absence of an objective explanation and they may not fit neatly into any known dermatological or psychiatric condition. These disorders are more commonly encountered in primary care and in dermatology, rather than in psychiatry. Certain skin disorders, for example, pruritus, could be a manifestation of somatization and others may predispose to somatic symptoms, for example, atopic dermatitis and psoriasis. Although there has been increasing research in the interconnection between psychiatry and dermatology, psychodermatology is a relatively new crossover discipline in clinical practice and recognition of psychodermatological conditions, such as cutaneous somatic disorders, can be difficult. Somatization may occur with or without the existence of a dermatological disease. When a dermatological disorder is present, somatization should be considered when the patient is worrying too much about their skin, spending too much time and energy on it and especially if the patient also complains of many non-cutaneous symptoms. Purely cutaneous somatic conditions include for example, the genital pain syndromes or Gardner-Diamond syndrome, characterized by unexplained bruising, which usually affects women. Effective management tools may include mindfulness therapies, pharmacotherapy with selective serotonin reuptake inhibitors, tricyclic antidepressants and cognitive conduct therapy. Electroconvulsive therapy can also be considered in extremely rare cases for treatment of severe somatization on a background of mood disorders. This paper discusses somatization, its relationship to immunodermatoses and its relevance to clinical practice.
Identifiants
pubmed: 36479272
doi: 10.1002/ski2.164
pii: SKI2164
pmc: PMC9720197
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e164Informations de copyright
© 2022 The Authors. Skin Health and Disease published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.
Déclaration de conflit d'intérêts
George W. M. Millington is the Editor in Chief of Skin Health and Disease.
Références
Br J Dermatol. 2018 Jan;178(1):34-60
pubmed: 29357600
Psychother Psychosom. 2000 Jul-Aug;69(4):205-15
pubmed: 10867588
Psychosom Med. 2011 Nov-Dec;73(9):760-8
pubmed: 22048838
Life (Basel). 2021 Dec 20;11(12):
pubmed: 34947965
Soc Sci Med (1967). 1977 Jan;11(1):3-10
pubmed: 887955
Clin Exp Dermatol. 2020 Jan;45(1):15-19
pubmed: 31456245
Medicine (Baltimore). 2015 Jun;94(23):e949
pubmed: 26061325
Br J Dermatol. 2006 Jan;154(1):61-6
pubmed: 16403095
Dialogues Clin Neurosci. 2018 Mar;20(1):23-31
pubmed: 29946208
Am Fam Physician. 2016 Jan 1;93(1):49-54
pubmed: 26760840
Int Rev Psychiatry. 2006 Feb;18(1):41-7
pubmed: 16451879
Clin Exp Dermatol. 2016 Mar;41(2):119-23
pubmed: 26871710
Br J Community Nurs. 2016 Jun;21(6):274, 276, 278-9
pubmed: 27270194
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2160-2168
pubmed: 34112472
Clin Dermatol. 2017 May - Jun;35(3):246-251
pubmed: 28511820
Am J Psychiatry. 1997 Jul;154(7):989-95
pubmed: 9210751
Pharmacogenomics. 2008 Dec;9(12):1835-50
pubmed: 19072642
Skin Health Dis. 2021 Feb 18;1(2):e17
pubmed: 35664978
Acta Derm Venereol. 2012 Jan;92(1):67-72
pubmed: 21879243
Pharmaceuticals (Basel). 2021 Jan 08;14(1):
pubmed: 33430064
Gen Hosp Psychiatry. 2019 Jan - Feb;56:36-41
pubmed: 30578985
Front Psychol. 2020 May 19;11:836
pubmed: 32508706
Am J Physiol Regul Integr Comp Physiol. 2021 Dec 1;321(6):R982-R989
pubmed: 34755553
Clin Exp Dermatol. 2020 Jan;45(1):20-24
pubmed: 31468592
Georgian Med News. 2021 Jun;(315):29-33
pubmed: 34365421
BMJ Case Rep. 2019 Nov 25;12(11):
pubmed: 31772129
Int J Dermatol. 2020 May;59(5):551-560
pubmed: 31773724
Int J Mol Sci. 2018 Mar 26;19(4):
pubmed: 29587417
An Bras Dermatol. 2017 Jul-Aug;92(4):510-515
pubmed: 28954100
Acta Derm Venereol. 1996 Nov;76(6):467-71
pubmed: 8982414
Clin Dermatol. 2017 May - Jun;35(3):252-259
pubmed: 28511821
Psychiatr Danub. 2017 Dec;29(4):401-406
pubmed: 29197196
North Clin Istanb. 2021 Apr 14;8(3):310-313
pubmed: 34222815
Curr Neuropharmacol. 2019;17(8):697-702
pubmed: 29701157
J Psychosom Res. 2009 May;66(5):363-77
pubmed: 19379952
Skin Health Dis. 2021 May 03;1(2):e33
pubmed: 35664982
Adv Biomed Res. 2021 Feb 26;10:9
pubmed: 33959566
J Clin Med. 2020 Sep 25;9(10):
pubmed: 32992983